ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Endra Life Sciences Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.409 -- 00:00:04.932 and welcome to the Endure Life Sciences fourth quarter 2023 00:00:04.932 -- 00:00:10.135 financial results conference call. All participants will be in listen-only mode. 00:00:10.135 -- 00:00:15.018 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.018 -- 00:00:20.201 key followed by zero. After today's presentation, there will be an opportunity 00:00:20.201 -- 00:00:25.224 to ask questions. To ask a question, you may press star then one on your 00:00:25.224 -- 00:00:30.998 telephone keypad. To withdraw your question, please press star, then two. 00:00:30.998 -- 00:00:36.119 Please note this event is being recorded. I would now like to turn the call over 00:00:36.119 -- 00:00:39.740 to Yvonne Briggs. Please go ahead. 00:00:39.740 -- 00:00:42.841 Thank you, operator. This is Yvonne Briggs with LHA. 00:00:42.841 -- 00:00:47.362 Good afternoon and welcome to Endra Life Sciences' fourth quarter 2023 00:00:47.362 -- 00:00:50.303 Business Update and Financial Results conference call. 00:00:50.303 -- 00:00:54.544 Earlier today, Endra issued a press release on this topic, which is available in the 00:00:54.544 -- 00:00:59.847 Investors section of Endra's website. Before we begin, please note that today's 00:00:59.847 -- 00:01:02.988 discussion will include forward-looking statements. 00:01:02.988 -- 00:01:07.270 All statements by management, other than statements of historical facts, are forward-looking 00:01:07.270 -- 00:01:12.772 statements. These include statements regarding the company's strategies, financial condition, 00:01:12.772 -- 00:01:16.814 operations, costs, plans, and objectives, 00:01:16.814 -- 00:01:21.936 as well as anticipated results of development and commercialization effor...